International Clinical Trial: A Single-Arm Clinical Study of Concurrent Chemoradiotherapy with Cetuximab and Induction Therapy with TP Chemotherapy Combined with Tislelizumab for HPV-Negative, Stage IVA-IVB Head and Neck Squamous Cell Carcinoma

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132973) titled 'A Single-Arm Clinical Study of Concurrent Chemoradiotherapy with Cetuximab and Induction Therapy with TP Chemotherapy Combined with Tislelizumab for HPV-Negative, Stage IVA-IVB Head and Neck Squamous Cell Carcinoma' on Sept. 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Army Medical University

Condition: head and neck squamous cell carcinoma

Intervention: Intervention group:1.TP chemotherapy rInduction therapy: TP chemotherapy (nab-paclitaxel + carboplatin: nab-paclitaxel 260 mg/m2, intravenous infusion, Day 1

Recruitment Status: Not Recru...